BioHarvest Sciences (BHST) Competitors $5.80 -0.03 (-0.51%) As of 01/21/2025 03:10 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsTrends BHST vs. ABVX, TERN, RVNC, ETON, CYRX, ALMS, RIGL, KRRO, MBX, and PGENShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include ABIVAX Société Anonyme (ABVX), Terns Pharmaceuticals (TERN), Revance Therapeutics (RVNC), Eton Pharmaceuticals (ETON), Cryoport (CYRX), Alumis (ALMS), Rigel Pharmaceuticals (RIGL), Korro Bio (KRRO), MBX Biosciences (MBX), and Precigen (PGEN). These companies are all part of the "pharmaceutical preparations" industry. BioHarvest Sciences vs. ABIVAX Société Anonyme Terns Pharmaceuticals Revance Therapeutics Eton Pharmaceuticals Cryoport Alumis Rigel Pharmaceuticals Korro Bio MBX Biosciences Precigen ABIVAX Société Anonyme (NASDAQ:ABVX) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk. Do institutionals & insiders believe in ABVX or BHST? 47.9% of ABIVAX Société Anonyme shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, ABVX or BHST? BioHarvest Sciences has higher revenue and earnings than ABIVAX Société Anonyme. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABIVAX Société AnonymeN/AN/A-$159.90MN/AN/ABioHarvest Sciences$12.67M7.52-$12.56M-$1.25-4.64 Does the media refer more to ABVX or BHST? In the previous week, BioHarvest Sciences had 1 more articles in the media than ABIVAX Société Anonyme. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for ABIVAX Société Anonyme. ABIVAX Société Anonyme's average media sentiment score of 1.46 beat BioHarvest Sciences' score of 1.36 indicating that ABIVAX Société Anonyme is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABIVAX Société Anonyme 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ABVX or BHST? ABIVAX Société Anonyme received 7 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 81.82% of users gave ABIVAX Société Anonyme an outperform vote. CompanyUnderperformOutperformABIVAX Société AnonymeOutperform Votes981.82% Underperform Votes218.18%BioHarvest SciencesOutperform Votes2100.00% Underperform VotesNo Votes Is ABVX or BHST more profitable? ABIVAX Société Anonyme has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -76.65%. Company Net Margins Return on Equity Return on Assets ABIVAX Société AnonymeN/A N/A N/A BioHarvest Sciences -76.65%N/A -85.16% Do analysts recommend ABVX or BHST? ABIVAX Société Anonyme presently has a consensus price target of $38.67, suggesting a potential upside of 507.01%. BioHarvest Sciences has a consensus price target of $13.00, suggesting a potential upside of 124.14%. Given ABIVAX Société Anonyme's higher probable upside, equities research analysts plainly believe ABIVAX Société Anonyme is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ABIVAX Société Anonyme 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryABIVAX Société Anonyme beats BioHarvest Sciences on 8 of the 12 factors compared between the two stocks. Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$95.24M$6.56B$5.38B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E Ratio-4.649.3686.9417.29Price / Sales7.52329.751,267.38137.12Price / CashN/A22.6336.6032.88Price / Book-5.375.084.974.69Net Income-$12.56M$154.90M$117.89M$224.57M7 Day Performance-2.52%1.33%1.72%1.69%1 Month Performance-7.79%1.51%3.67%5.34%1 Year PerformanceN/A4.60%26.11%21.47% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$5.80-0.5%$13.00+124.1%N/A$95.24M$12.67M-4.64N/ANews CoveragePositive NewsHigh Trading VolumeABVXABIVAX Société Anonyme2.4689 of 5 stars$6.09-2.3%$38.67+535.4%-44.9%$383.90MN/A0.0061TERNTerns Pharmaceuticals3.8017 of 5 stars$4.52+0.3%$18.30+305.3%-8.4%$383.50MN/A-3.8340RVNCRevance Therapeutics4.2031 of 5 stars$3.66+11.8%$8.39+129.4%-35.2%$381.55M$234.04M-1.89500Analyst ForecastOptions VolumeHigh Trading VolumeETONEton Pharmaceuticals2.4893 of 5 stars$14.60+2.2%$18.67+27.9%+268.8%$380.46M$31.64M-66.3920CYRXCryoport3.4308 of 5 stars$7.48-0.2%$12.29+64.4%-43.5%$365.29M$233.26M-2.191,170Positive NewsGap DownALMSAlumisN/A$7.56-2.9%$26.83+254.9%N/A$358.40MN/A0.00N/APositive NewsRIGLRigel Pharmaceuticals4.1679 of 5 stars$19.87+14.5%$36.20+82.2%+60.4%$348.62M$157.47M141.37160KRROKorro Bio1.5319 of 5 stars$36.92-0.2%$144.00+290.0%-8.5%$345.94MN/A0.0070MBXMBX BiosciencesN/A$9.92-5.8%$37.25+275.4%N/A$331.69MN/A0.0036PGENPrecigen3.9681 of 5 stars$1.12+0.5%$6.33+468.0%-7.8%$326.55M$6.22M-2.03190 Related Companies and Tools Related Companies ABIVAX Société Anonyme Competitors Terns Pharmaceuticals Competitors Revance Therapeutics Competitors Eton Pharmaceuticals Competitors Cryoport Competitors Alumis Competitors Rigel Pharmaceuticals Competitors Korro Bio Competitors MBX Biosciences Competitors Precigen Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BHST) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
